Pontifax Management 4 GP 2015 Ltd

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Pontifax Management 4 GP 2015 Ltd
CIK #0001726334
EDGAR Form CIK 2011 - 2026
3 [0001726334]
4 [0001726334]
SC 13D [0001726334]
SC 13G [0001726334]
Form 13D/13G Filer Form 13D/13G Subject Filed
Pontifax Management 4 GP 2015 Ltd Agomab Therapeutics NV [2026-04-16]
Pontifax Management 4 GP 2015 Ltd Nuvectis Pharma Inc [2024-02-06]
Pontifax Management 4 GP 2015 Ltd Keros Therapeutics Inc [2020-04-23]
Pontifax Management 4 GP 2015 Ltd Arqule Inc [2018-06-28]
Pontifax Management 4 GP 2015 Ltd Eloxx Pharmaceuticals Inc [2018-01-02]
Form 3/4/5 Subject 2011 - 2026
Keros Therapeutics Inc
Nussbaum Ran
Pontifax Late Stage Fund LP
Pontifax Late Stage GP Ltd
Kariv Tomer
Pontifax Cayman IV LP
Pontifax China IV LP
Pontifax Israel IV LP
Pontifax Management 4 GP 2015 Ltd
Pontifax IV GP LP
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Keros Therapeutics Inc KROS
Common Stock, $0.0001 par value per share
2025-10-15 Sell 155,262 $17.75 2,755,900
Keros Therapeutics Inc KROS
Common Stock, $0.0001 par value per share
2025-10-15 Sell 1,226,412 $17.75 21,768,813
Keros Therapeutics Inc KROS
Common Stock, $0.0001 par value per share
2025-10-15 Sell 1,121,045 $17.75 19,898,549
Keros Therapeutics Inc KROS
Common Stock, $0.0001 par value per share
2025-10-15 Sell 2,284,612 $17.75 40,551,863
Keros Therapeutics Inc KROS
Common Stock
2022-11-29 Option exercise 1,723 $0.00
Keros Therapeutics Inc KROS
Common Stock
2022-11-29 Option exercise 1,914 $0.00
Keros Therapeutics Inc KROS
Common Stock
2022-11-29 Option exercise 3,539 $0.00
Keros Therapeutics Inc KROS
Call Options (obligation to sell) · derivative
2022-11-29 Option exercise 1,914 $0.00
Keros Therapeutics Inc KROS
Call Options (obligation to sell) · derivative
2022-11-29 Option exercise 3,539 $0.00
Keros Therapeutics Inc KROS
Call Options (obligation to sell) · derivative
2022-11-29 Option exercise 1,723 $0.00
Senesco Technologies Inc ELOX
Common Stock
2021-05-13 Buy 1,280,624 $1.35 1,728,842
Senesco Technologies Inc ELOX
Common Stock
2021-05-13 Buy 592,592 $1.35 799,999
Senesco Technologies Inc ELOX
Common Stock
2021-05-13 Buy 1,422,222 $1.35 1,920,000
Senesco Technologies Inc ELOX
Common Stock
2021-05-13 Buy 2,630,487 $1.35 3,551,157
Keros Therapeutics Inc KROS
Common Stock
2020-11-17 Buy 14,400 $50.00 720,000
Keros Therapeutics Inc KROS
Common Stock
2020-11-17 Buy 12,966 $50.00 648,300
Keros Therapeutics Inc KROS
Common Stock
2020-11-17 Buy 6,000 $50.00 300,000
Keros Therapeutics Inc KROS
Common Stock
2020-11-17 Buy 26,634 $50.00 1,331,700
Senesco Technologies Inc ELOX
Stock Option (Right to Buy) · derivative
2020-05-20 Grant 20,000 $0.00
Senesco Technologies Inc ELOX
Stock Option (Right to Buy) · derivative
2020-05-20 Grant 20,000 $0.00
showing 20 of 66 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com